This prospective, randomized, single-blinded, clinical study aimed at evaluating 3 different synthetic wound dressings for treating split-thickness skin graft donor sites. Seventy-seven patients were randomly assigned to 3 study groups: Suprathel, Biatain-Ibu, Mepitel. Wounds were inspected daily until complete reepithelization. Ease of care, treatment costs, and scar development after a 6 months follow-up were evaluated. Suprathel showed significant (P Յ 0.001) pain reduction after 24 hours but increasing pain scores on the 5th day of treatment. Biatain-Ibu showed significant pain relief immediately after application and during the entire treatment period (P Ͻ 0.05). Mepitel did not show any significant pain reduction. No differences were seen with regard to healing time, quality of reepithelization, and scar development. Biatain-Ibu had the lowest overall treatment costs (P Յ 0.001). The investigated materials did not differ with regard to quality and acceleration of the healing process, but Biatain-Ibu seems to be the most appropriate dressing material in terms of cost-effectiveness.
T he ideal postoperative care of split-thickness skin graft donor sites has been discussed in many studies on dressing comparisons. The common goals of all dressing methods are to achieve rapid wound healing without causing disorders of pigmentation or scarring, to minimize pain, and to offer adequate ease of care. 1 Moreover, cost-effectiveness has become an important issue in wound management. 2 In this study, we report our experience with 3 different wound dressings: Mepitel (M), Suprathel (S), and Biatain-Ibu (B). In contrast to the well-established material Mepitel, the other 2 dressing materials have been only recently introduced into modern wound therapy. 3, 4 
MATERIALS AND METHODS
Between August 2006 and March 2008, a prospective randomized single-blinded clinical study was conducted at the Department of Plastic Surgery at the University Hospital Regensburg, Germany. We enrolled 77 patients aged between 18 and 85 years into the study, after having obtained their written consent as well as authorization from the Ethics Committee of the University of Re-gensburg. The study evaluated pain scores, healing time, quality of reepithelialization, scar formation, patient comfort, ease of care, and treatment costs.
Wound Dressing Material
Suprathel (PolyMedics Innovations, Filderstadt, Germany), an artificial skin substitute that imitates the properties of natural epithelium, is considered a temporary skin substitute. 5 The membrane adapts instantly to wound surfaces and becomes transparent during the course of wound healing, allowing the evaluation of wound ground without manipulating the wound dressing itself. During the wound healing process, the membrane is supposed to automatically detach from wound surfaces, which involves a sufficient impact on pain reduction. The effectiveness and reliability of Suprathel in treating partial thickness burns and split-thickness skin graft donor sites has already been shown. 6 Biatain-Ibu nonadhesive foam dressing (Coloplast A/S, Humlebaek, Denmark) consists of an advanced foam with incorporated ibuprofen ͓nonsteroidal anti-inflammatory drug (NSAID)͔. Ibuprofen is released to wounds if fluid or wound exudate are present. 7 A positive impact of topically applied anesthetics on pain reduction has been reported in skin graft donor sites. 8, 9 In contrast to anesthetics investigated in prior studies, ibuprofen does not block voltage-dependent sodium channels but inhibits cyclooxygenase and thus reduces local release of inflammatory mediators. 10 Recent studies have indicated that Biatain-Ibu may reduce pain, particularly during dressing changes. 11, 12 Mepitel (SCA Mölnlycke Health Care Ltd, Bedfordshire, UK) is a sterile nonadhesive silicone net dressing without biologic components. This material does not adhere to wound surfaces or other absorbent dressing materials and is supposed to allow the removal of dressings without dislodging newly regenerated epithelium. In our department, this dressing is the most commonly used material in the treatment of split-thickness skin graft donor sites. The properties of all dressing materials investigated are presented in Table 1 .
Eligibility and Treatment Protocol
Patients with major systemic diseases, immunosuppressive disorders, dementia, and any history of allergic reactions toward Ibuprofen or Silicone were excluded. Preexisting split-thickness skin graft donor sites were not reharvested. To avoid differences in pain perception on the basis of varying densities of specific types of nerve endings in different body parts, 13 all skin grafts were taken from the anteromedial and anterolateral thigh area. Skin grafts were harvested by use of an electric dermatome (Aesculap GA 630) with a common cut depth of 0.3 mm. Treatment consistency was achieved by harvesting in one-pass technique that was always performed by the same surgeon. Immediately after harvesting, all donor sites were measured and covered with saline-soaked gauzes for hemostasis until completion of surgery. To avoid any side effects of the anesthetics administered during surgery, all donor sites were initially covered with paraffin gauze (Jelonet) for 6 hours after surgery. Before applying the dressing material, patients' pain perception was evaluated with the Visual Analogue Scale (VAS) (0 indicating no pain; 10 indicating unbearable pain). 14 According to randomization, patients were distributed into 3 different study groups. In the first group, donor sites were treated with Mepitel, in the second group, treatment consisted of Suprathel, and in the third group of Biatain-Ibu. Additional dry cotton gauzes were applied directly on top of Mepitel, and a paraffin gauze (protective interlayer) with dry cotton gauzes on top of Suprathel. Biatain-Ibu did not require any additional dressing material. All patients were further protected from dressing dislocation by regular compression garments.
Patients' pain sensation was recorded 3 hours after the first dressing application, followed by a daily pain evaluation on a regular 12-hour schedule until the seventh postoperative day. Pain and wounds were assessed, with careful changes of dry cotton gauzes without manipulation of the investigated dressing materials, by the same experienced plastic surgeon at the same hour of each day, thus allowing the inspection and evaluation of the wound surface and the healing process ( Table 2 ). Reepithelization (shining epithelial layer without any residual wound exudation) was evaluated on a regular basis until complete reepithelization. In patients treated with Suprathel, reepithelization was defined by automatic painless material detachment from wound surfaces. In selected patients, punch biopsies (5 mm) for histologic examination were taken on day 10 to evaluate the quality of reepithelization and tissue regeneration. In case of dressing dislocation or severe wound exudation based on clinical judgment, the old dressing material was removed and new material was applied. In case of clinical signs of infection, swabs of bacterial examination were taken. Patients were not mobilized until the fifth postoperative day. After complete reepithelization, donor sites were treated with moisturizing creams and local compression (elastic garments). After a follow-up period of 6 months, all donor sites were evaluated with the Vancouver Scar Scale parameters (VSS) ( Table 3) . 15 Costs were analyzed by comprising costs of material and nursing and physician care.
Data Collection
Pain scores were evaluated on a daily basis according to the 10-point VAS system. We ascertained the duration of the healing process until full reepithelization, the quality of tissue regeneration, and the ease of care. Evaluation of treatment costs included direct material costs (Mepitel, Suprathel, Biatain-Ibu), all costs of regular dressing materials required, and the costs of nursing and physician care. Scars were assessed according to VSS parameters following a cumulative scoring system (Table 4 ). Photographs were taken before, during, and after reepithelization ( Fig. 2 ).
Statistical Analyses
All statistical analyses were conducted by means of Sigma Stat 3.5 (Systat Software Inc., Chicago, IL). Data are given as mean Ϯ SD for age, defect size, number of dressing exchanges, and time values. Differences between wound healing times were analyzed with the Wilcoxon-Signed Rank test and, for comparing different sample sizes, the Mann-Whitney Rank Sum test. VAS data are given as median (max, 
RESULTS

Patients and Surgical Procedure
Seventy-seven patients (51 men, 26 women) with a mean age of 57.6 years (range: 18 -85 years) were included into this study (B: n ϭ 27, S: n ϭ 22, M: n ϭ 28) ( Fig. 1 ). About 93.5% (n ϭ 72) of the enrolled participants completed the study, 5 participants were excluded because of noncompliance. The mean donor site wound area was 123.1 cm 2 (range: 12-598 cm 2 ). During the entire treatment period, no infection or allergic reactions occurred. The mean time between the skin graft harvest and the assessment of the initial pain score was 6.25 hours (range: 4 -12 hours). Figure 2 shows the application and outcome of the materials used ( Fig. 1 ).
FIGURE 2.
Pain score during a 7-day treatment period with Suprathel evaluated with VAS. 
Pain Levels
In the Suprathel group, the reduction of evaluated pain scores compared with initial pain scores was statistically significant (P Ͻ 0.05) at 12 and 24 hours after dressing application (24 -128 hours) (P Յ 0.001), but not 3 hours after material application. After 120 hours of treatment, pain scores raised temporarily (still with significant pain reduction compared with initial pain scores) and returned to highly significantly reduced levels 168 hours after initial dressing application (Fig. 2) . Biatain-Ibu showed a statistically significant reduction of pain scores (P Ͻ 0.05) at all times of pain evaluation from the first application onwards. After 168 hours of treatment, pain reduction was highly significant (P Յ 0.001) ( Fig. 3 ). Mepitel did not show any statistically significant reduction of pain scores compared with the initially evaluated scores at any time of pain assessment after dressing application (Fig. 4 ).
Reepithelialization
Statistically, no significant differences existed in the reepithelization period of the 3 dressing materials (Suprathel, Biatain-Ibu, Mepitel) (P Ͼ 0.05). Donor site areas treated with Suprathel showed reepithelization after a mean 12.9-day period (median: 13, range: 8 -19) ; areas treated with Biatain-Ibu after 12.8 days (median: 13, range: 8 -18), and areas treated with Mepitel after 12.69 days (median: 13, range: 9 -16) ( Table 5 ). For Suprathel and Biatain-Ibu, the selected histologic paraffin section (5 m) stained with hematoxylin and eosin showed a complete and intact epidermis including a horny layer, whereas some wounds dressed with Mepithel showed a partly incomplete epidermis.
Dressing Changes
A comparison of the number of dressing changes between the 3 study groups showed significant differences (P Յ 0.001): Suprathel (mean: 0.30; range: 0 -3) was changed less frequently than Biatain-Ibu (mean: 1.46; range: 1-3) and Biatain-Ibu required fewer dressing changes than Mepitel (mean: 4,0; range: 2-7). Furthermore, differences in the duration of dressing changes were statistically significant: dressing changes with Suprathel required less time (mean: 2.25 minutes; range: 0 -15 minutes) than those with Mepitel (mean: 10.58 minutes; range: 5-25 minutes) (P Յ 0.001). Dressing changes in the Biatain-Ibu group were the most time-consuming (mean: 11.54 minutes; range: 5-30 minutes), but no significant difference existed between Mepitel and Biatain-Ibu (P Ͼ 0.05).
Treatment Effort
Statistically (P Յ 0.001), overall treatment effort (daily nursing and physician care for daily wound treatment) until complete reepithelization was lowest for Suprathel (mean: 3.75 minutes; range: 0 -45 minutes) followed by Biatain-Ibu (mean: 17.12 minutes; range: 5-60 minutes); Mepitel required the most treatment effort (mean: 43.08 minutes; range: 10 -105 minutes) ( Table 6 ).
Scar Development
Analysis of evaluated scores of scar development based on the Vancouver Scar Scale did not show any statistically significant (P Ͼ 0.05) differences between Suprathel (mean: 4.950; range: 0 -10), Biatain-Ibu (mean: 5.077; range: 0 -12), and Mepitel (mean: 4.462; range: 0 -13). Best results for wound fluid management could be shown for Biatain-Ibu (mean: 1.692; range: 1-3) and Suprathel (mean: 1,450; range: 1-3) in contrast to Mepitel (mean: 2.538; range: 1-4). Statistical analysis of wound fluid management showed a significant difference between Mepitel and the other 2 materials (P Յ 0.001). No statistical difference existed between Suprathel and Biatain-Ibu (P Ͼ 0.05) (Fig. 5 ).
Treatment Costs
Analysis of overall treatment costs showed the following statistically significant differences (P Յ 0.001) ( Fig. 6 ): overall treatment costs were higher for Suprathel (mean: 151.01 €; range: 45-750.15 €) than for Mepitel (mean: 55.18 €; range: 13.4 -108.75 €) and lowest for Biatain-Ibu (mean: 30.35 €; range: 9.89 -111.94 €). Statistically, material costs until complete reepithelization were highest (P ՅՅ 0.001) in the Suprathel study group (mean: 148.50 €; range: 45-720 €). Mepitel (mean: 26.34 €; range: 6.70 -70.20 €) involved significantly higher (P Ͻ 0.05) material expenses than Biatain-Ibu (mean: 18.89 €; range: 6.54 -71.94 €). Costs and effort of nursing and physician care were statistically the highest (P Յ 0.001) in the Mepitel group (mean: 28.84 €; range: 6.70 -70.35 €) followed by Biatain-Ibu (mean: 11.46 €; range: 3.35-40 €). Treatment with Suprathel required the lowest (P Յ 0.001) expenses for nursing and physician care (mean: 2.51 €; range: 0 -30.15 €) ( Table 7) . 
DISCUSSION
The treatment of split-thickness donor sites demands several qualities from modern wound dressings: pain minimization, promotion of reepithelization, ease of care, and cost-effectiveness. Numerous wound dressings, particularly synthetic or biologic materials, have been developed and introduced that take these objectives into account. 16, 17 In this study, we compared the quality and efficiency of 3 synthetic dressing materials with different properties and targets, each preserving a moist wound environment as well as enhancing reepithelialization and pain relief. 18 In split-thickness skin grafting, pain represents a common complaint that often occurs more severely at donor sites than in areas of grafted sites. In accordance with the results of other studies, 19 -22 we observed significant pain reduction in patients treated with Suprathel and Biatain-Ibu. Despite prior investigations indicating significant pain relief under treatment with silicon-coated wound dressings, 23 Mepitel did not result in any significant pain reduction in our study. The insufficient pain management in the Mepitel group seems to be related to both the high frequency of dressing changes required and to the dislocation of material which causes epithelial damage during every change. 24, 25 We also observed that covering layers of cotton dressings on top of Mepitel often bonded to wound surfaces, causing difficult and delayed dressing changes. In contrast to Suprathel, which gradually decreased pain over a 24-hour period, Biatain-Ibu induced immediate pain relief after its application. This pain reduction has been assumed to be related to the immediate release of incorporated ibuprofen together with a moist wound environment. 7, 26 Surprisingly, patients treated with Suprathel experienced particular pain increase on the fifth day of treatment, particularly if starting mobilization. In contrast to previous studies reporting good material elasticity throughout the entire process of reepithelization, 19, 27 we observed only minor elastic properties of Suprathel as the material became fairly rigid after its application (48 hours). However, elasticity during the initial application was excellent. Therefore, we hypothesize that the increased pain scores on the fifth postoperative day may be related to patient mobilization that induces untimely detachments from wound surfaces because of the development of material rigidity. Nevertheless, Suprathel detachment correlated well with stages of reepithelization. In the Biatain-Ibu group, interim pain peaks occurred 2 days after material application with immediate resolution after reapplication of new material. We believe this to be related partly to decreased drug concentrations incorporated in the dressing, and partly to dressing changes at this particular time of treatment. 28 In addition, similar to Mepitel, Biatain-Ibu occasionally severely adhered to wound surfaces (after 48 -72 hours), thus causing painful material removal with elevated pain scores.
Because of the materials' different reaction patterns and frequencies in dressing changes, particularly in the Mepitel group, we expected major differences in the durations of wound healing. 29 -31 Suprathel, which is supposed to automatically detach from wound surfaces without any material manipulation, was expected to accelerate the healing process with the least time required for reepithelization. 6 Surprisingly, each of 3 dressing materials required the same period of time for the reepithelization process ( Table 5) . It remains open if this similarity may be related to the synthetic property of the membranes or to the moist wound environment or both. 29, 30 Moreover, scar assessment of donor sites 6 months after surgery showed similar results of regeneration and reepithelization. However, it should be taken into account that scar evaluation was based on a clinical scoring system (VSS) associated with limited objectivity because of the personal experience of the investigator. Mepitel and Biatain-Ibu required complex and time-consuming dressing changes, whereas Suprathel showed best ease of care: easy and precise initial application with excellent material elasticity and no necessary material removal from wound surfaces. However, in contrast to previous studies, 3, 32 continuous wound bed monitoring in wounds treated with Suprathel remained difficult because of insufficient material transparency.
A comparison of overall treatment costs showed that Suprathel represented the most expensive dressing material with the highest treatment costs ( Table 6 ). Although this dressing significantly minimizes the amount of nursing and physician care, its high purchase prize makes treatment least cost-effective. In contrast, Biatain-Ibu showed the best ratio between treatment effectiveness and cost effectiveness. In conjunction with sufficient pain reduction and an appropriate amount of nursing care, this wound dressing proved the most suitable synthetic material in this study.
CONCLUSIONS
In conclusion, the investigated materials do not differ with regard to quality or acceleration of healing process of split-thickness donor sites. Differences between the products are related to pain relief, ease of care, and cost-effectiveness. Mepitel does not seem to be the dressing material of first choice when dealing with splitthickness donor sites. Suprathel may represent a suitable treatment option, but the high purchase prize limits its application. With regard to pain management, material handling, and treatment costs, our study showed Biatain-Ibu to be the most appropriate dressing material for treating split-thickness donor sites. 
